More on EMIS
Financials
News
Click line-items for a historical chart and %
| Net Sales | |
| Research and development | 89K |
| General and administrative | 1.32M |
| Restructuring costs | |
| Gain on disposal of fixed assets | |
| Expense from settlement of lawsuit | |
| Depreciation and amortization | 3K |
| Total costs and expenses | |
| Operating loss | -1.97M |
| Other income | |
| Related party | |
| Other | 83K |
| Related party | -2.64M |
| Other | |
| Loss on extinguishment of debt | |
| Financing fees | |
| Total other non-operating income (expense) | |
| Net income (loss) | -7.51M |
| Net income (loss) per share, basic | -0.12 |
| Net income (loss) per share, diluted | -0.12 |
| Weighted average shares outstanding, basic | 60.69M |
| Weighted average shares outstanding, diluted | 60.69M |
Entities mentioned with EMIS
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- 13D | View Related Stories »
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Jefferies & Co | View Related Stories »
- Carl Icahn | View Related Stories »
- Show More...
